Sonova Raises Fiscal 2027 Sales and Profit Guidance
The world's largest hearing-aid maker lifted its outlook, citing market-share gains and strong uptake of its AI-powered EON platform.
Updated on Nov. 12, 2026 in Healthcare

Swiss hearing-aid maker Sonova raised its fiscal 2027 sales and profit guidance, now expecting sales to rise 6% to 8% in local currency and core operating profit to grow 10% to 13%. The company cited gains in market share and solid uptake of new products.
Why it matters
The upgrade signals continued momentum for the global hearing-aid market, which Sonova now expects to grow 3% to 5% this year. It comes after rival Demant also raised its full-year guidance for the second time this year in October.
Sonova's revised outlook raises sales growth to 6% to 8% in local currency and core operating profit growth to 10% to 13%, while Asia-Pacific sales rose 11.4% to 186.9 million francs in the first half of the fiscal year. Hearing Instruments growth in the region reached the mid-teens, led by Australia, China and Japan, though the filing does not detail how these figures may evolve.
The players
Sonova
Sonova is a Swiss hearing-aid maker and the world's largest producer of hearing aids, known for its Phonak brand.
Eric Bernard
Eric Bernard is the chief executive of Sonova, who spoke about the early performance of the company's EON platform.
The details
Sonova credited higher market share and solid uptake of new products for the guidance increase. CEO Eric Bernard said the AI-powered Phonak EON platform is already contributing above the company's expectations.
Timeline
October: Rival Demant raised its full-year guidance for the second time this year.
November 12, 2026: Sonova announced the raised fiscal 2027 sales and profit guidance.
Through March 2027: The fiscal 2027 guidance period covers the revised sales and profit forecasts.
Market Landscape
Sonova's upgrade places it ahead in a hearing-aid sector where rival Demant has also raised guidance twice this year. The company's Phonak EON platform, rolled out across markets, is central to its gains in market share.
Consumers considering a hearing aid may see continued product innovation from Sonova's EON platform as the market expands. The company's guidance suggests growing availability of AI-enabled devices in the coming fiscal year.
The takeaway
Sonova's raised outlook shows that AI-enabled hearing aids are gaining traction with buyers and lifting the company's position in a growing global market. Readers tracking the sector should watch whether rivals match these gains in the months ahead.
Further reading
For more on the industry behind this outlook, explore Healthcare coverage.



